Rhenman & Partners Asset Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-80,369	Closed	-$2.03M	–	105
2014 Q3	$2.03M	Buy	80,369 +10,000	+14%	+$248K	0.59%	69
2014 Q2	$1.84M	Sell	70,369 -3,333	-5%	-$85.7K	0.55%	67
2014 Q1	$1.9M	Sell	73,702 -36,298	-33%	-$983K	0.57%	64
2013 Q4	$2.22M	Buy	+110,000	New	+$2.59M	0.87%	50

Other funds holding HPTX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

HMPV

Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rhenman & Partners Asset Management's HPTX Position: Q4 2014 in Review

Rhenman & Partners Asset Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q4 2014, closing a stake of 80,369 shares — an estimated $2.03M sold.

Rhenman & Partners Asset Management first reported a position in HPTX in Q4 2013 and held it in 4 quarters. The position peaked at $2.22M in Q4 2013. 106 funds tracked by Wall St. Rank hold HPTX as of Q4 2014.

Rhenman & Partners Asset Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Rhenman & Partners Asset Management sold 80,369 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $2.03M.
Rhenman & Partners Asset Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q4 2013 and held it in 4 quarters.
Rhenman & Partners Asset Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $2.22M in Q4 2013.
106 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2014, filed 9 Feb 2015.